Literature DB >> 6615508

Neonatal phenobarbital administration results in increased cytochrome P450-dependent monooxygenase activity in adult male and female rats.

D M Bagley, J R Hayes.   

Abstract

The effects of neonatal exposure to phenobarbital during the first five days after birth on the enzymatic activity of the adult male and female rat liver P450-dependent monooxygenase system were investigated. Although liver weight per 100 grams of body weight and total hepatic microsomal protein content were not altered in adult rats treated neonatally with phenobarbital, both sexes did show significant increases in cytochrome P450 content, cytochrome P450 reductase activity, cytochrome c reductase activity, ethoxycoumarin-O-deethylase activity and in the activity of a specific glucuronyl-transferase. Several of these activities were increased to a larger extent in the females, suggesting that females may be more sensitive to this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615508     DOI: 10.1016/0006-291x(83)90680-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.

Authors:  Stephanie Piekos; Chad Pope; Austin Ferrara; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

Review 2.  Role of nutritional programming in determining adult morbidity.

Authors:  A Lucas
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

3.  Effects of cimetidine on drug metabolism in rat pups.

Authors:  C O Ikediobi; H O Kwanashie; G Osuide; C Wambebe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

4.  Neuroimaging, a new tool for investigating the effects of early diet on cognitive and brain development.

Authors:  Elizabeth B Isaacs
Journal:  Front Hum Neurosci       Date:  2013-08-06       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.